Gene Symbol | Gene ID | Gene Info |
---|---|---|
Gli3
|
ENSMUSG00000021318.9 | GLI-Kruppel family member GLI3 |
Zic1
|
ENSMUSG00000032368.8 | zinc finger protein of the cerebellum 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr13_15468099_15468909 | Gli3 | 4524 | 0.200906 | 0.33 | 9.9e-03 | Click! |
chr13_15556577_15556728 | Gli3 | 92672 | 0.068047 | 0.31 | 1.7e-02 | Click! |
chr13_15469889_15470040 | Gli3 | 5984 | 0.191569 | 0.27 | 3.9e-02 | Click! |
chr13_15471931_15472082 | Gli3 | 8026 | 0.185463 | -0.25 | 5.2e-02 | Click! |
chr13_15466077_15468087 | Gli3 | 3102 | 0.223305 | 0.23 | 8.2e-02 | Click! |
chr9_91365715_91366080 | Zic1 | 87 | 0.942096 | -0.22 | 8.5e-02 | Click! |
chr9_91363965_91365514 | Zic1 | 1029 | 0.354698 | -0.15 | 2.4e-01 | Click! |
chr9_91363064_91363717 | Zic1 | 336 | 0.721275 | -0.07 | 6.0e-01 | Click! |
chr9_91366433_91367646 | Zic1 | 1229 | 0.263667 | -0.05 | 7.2e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr5_75148315_75152589 | 3.66 |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
1840 |
0.2 |
chr1_162220626_162221297 | 3.12 |
Dnm3os |
dynamin 3, opposite strand |
1093 |
0.42 |
chr5_147304305_147307985 | 2.35 |
Cdx2 |
caudal type homeobox 2 |
1125 |
0.33 |
chr8_70493071_70496051 | 2.30 |
Crlf1 |
cytokine receptor-like factor 1 |
1200 |
0.25 |
chr5_128581458_128581692 | 2.09 |
Fzd10os |
frizzled class receptor 10, opposite strand |
3803 |
0.19 |
chr7_44350602_44354420 | 2.08 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
1749 |
0.15 |
chr4_141242265_141243901 | 1.95 |
Arhgef19 |
Rho guanine nucleotide exchange factor (GEF) 19 |
190 |
0.9 |
chr1_74774517_74774765 | 1.94 |
Wnt6 |
wingless-type MMTV integration site family, member 6 |
2749 |
0.15 |
chr7_44603559_44604864 | 1.90 |
Kcnc3 |
potassium voltage gated channel, Shaw-related subfamily, member 3 |
8118 |
0.07 |
chr8_121080367_121081368 | 1.88 |
Fendrr |
Foxf1 adjacent non-coding developmental regulatory RNA |
2165 |
0.19 |
chr6_52239630_52240532 | 1.86 |
Hoxa10 |
homeobox A10 |
714 |
0.34 |
chr4_45848613_45849374 | 1.82 |
Stra6l |
STRA6-like |
4 |
0.97 |
chr1_78190727_78191957 | 1.75 |
Pax3 |
paired box 3 |
5496 |
0.25 |
chr19_56290869_56291020 | 1.67 |
Habp2 |
hyaluronic acid binding protein 2 |
2948 |
0.27 |
chr13_63568967_63570183 | 1.61 |
A930032L01Rik |
RIKEN cDNA A930032L01 gene |
1521 |
0.3 |
chr13_63557270_63560459 | 1.61 |
Ptch1 |
patched 1 |
4951 |
0.16 |
chr4_141536335_141538488 | 1.61 |
Spen |
spen family transcription repressor |
842 |
0.51 |
chr2_147186958_147188347 | 1.60 |
6430503K07Rik |
RIKEN cDNA 6430503K07 gene |
228 |
0.87 |
chr9_21961394_21962913 | 1.55 |
Epor |
erythropoietin receptor |
411 |
0.68 |
chr11_96325013_96326405 | 1.55 |
Hoxb3 |
homeobox B3 |
2353 |
0.11 |
chr2_172888308_172888459 | 1.53 |
Gm22773 |
predicted gene, 22773 |
24042 |
0.18 |
chr7_126864271_126864667 | 1.50 |
Hirip3 |
HIRA interacting protein 3 |
53 |
0.91 |
chr12_9578132_9580204 | 1.49 |
Osr1 |
odd-skipped related transcription factor 1 |
4727 |
0.2 |
chr17_24640017_24640237 | 1.47 |
Nthl1 |
nth (endonuclease III)-like 1 (E.coli) |
1951 |
0.13 |
chr7_142654280_142656231 | 1.47 |
Mir483 |
microRNA 483 |
259 |
0.76 |
chr11_50216236_50216513 | 1.45 |
Mgat4b |
mannoside acetylglucosaminyltransferase 4, isoenzyme B |
5484 |
0.11 |
chr1_171373770_171374453 | 1.41 |
Nectin4 |
nectin cell adhesion molecule 4 |
3756 |
0.08 |
chr13_63171587_63172141 | 1.40 |
Aopep |
aminopeptidase O |
19248 |
0.12 |
chr14_79420392_79420543 | 1.37 |
Kbtbd7 |
kelch repeat and BTB (POZ) domain containing 7 |
6044 |
0.15 |
chr2_74713881_74716227 | 1.34 |
Hoxd3os1 |
homeobox D3, opposite strand 1 |
942 |
0.23 |
chr9_43232895_43233046 | 1.31 |
Oaf |
out at first homolog |
6941 |
0.15 |
chr2_26646949_26647190 | 1.30 |
Snhg7os |
small nucleolar RNA host gene 7, opposite strand |
3180 |
0.12 |
chr4_148677455_148677606 | 1.28 |
Gm572 |
predicted gene 572 |
34213 |
0.11 |
chr3_87949543_87950464 | 1.28 |
Crabp2 |
cellular retinoic acid binding protein II |
1337 |
0.25 |
chr9_60139459_60140875 | 1.28 |
Thsd4 |
thrombospondin, type I, domain containing 4 |
1053 |
0.62 |
chr9_73102801_73104131 | 1.27 |
Khdc3 |
KH domain containing 3, subcortical maternal complex member |
956 |
0.29 |
chr16_20703929_20704191 | 1.27 |
Clcn2 |
chloride channel, voltage-sensitive 2 |
4674 |
0.08 |
chr4_135025591_135026111 | 1.27 |
Gm16225 |
predicted gene 16225 |
94596 |
0.05 |
chr13_56611164_56612950 | 1.26 |
Tgfbi |
transforming growth factor, beta induced |
2471 |
0.28 |
chr15_95527528_95528774 | 1.26 |
Nell2 |
NEL-like 2 |
27 |
0.99 |
chrX_137118132_137120673 | 1.25 |
Esx1 |
extraembryonic, spermatogenesis, homeobox 1 |
769 |
0.36 |
chr10_127339124_127340844 | 1.24 |
Gli1 |
GLI-Kruppel family member GLI1 |
25 |
0.94 |
chr18_32366277_32366690 | 1.24 |
A830052D11Rik |
RIKEN cDNA A830052D11 gene |
10569 |
0.18 |
chr14_67231738_67233661 | 1.23 |
Gm20675 |
predicted gene 20675 |
430 |
0.57 |
chr11_102364387_102365146 | 1.22 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
481 |
0.67 |
chr17_56591030_56591181 | 1.22 |
Safb |
scaffold attachment factor B |
2265 |
0.17 |
chr14_25607071_25608307 | 1.22 |
Zmiz1 |
zinc finger, MIZ-type containing 1 |
149 |
0.96 |
chr2_172040251_172043672 | 1.22 |
Cbln4 |
cerebellin 4 precursor protein |
1505 |
0.35 |
chr12_73039135_73040425 | 1.21 |
Six1 |
sine oculis-related homeobox 1 |
3035 |
0.27 |
chr12_73044500_73046647 | 1.21 |
Six1 |
sine oculis-related homeobox 1 |
282 |
0.92 |
chr10_127663577_127665208 | 1.20 |
Gm16229 |
predicted gene 16229 |
553 |
0.47 |
chr11_96326559_96328109 | 1.20 |
Hoxb3 |
homeobox B3 |
728 |
0.39 |
chr10_80697755_80698145 | 1.19 |
Mob3a |
MOB kinase activator 3A |
3878 |
0.1 |
chr6_145784225_145784376 | 1.19 |
Rassf8 |
Ras association (RalGDS/AF-6) domain family (N-terminal) member 8 |
24083 |
0.17 |
chr15_77160067_77160599 | 1.18 |
Rbfox2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
6521 |
0.15 |
chr2_105125289_105128976 | 1.17 |
Wt1 |
Wilms tumor 1 homolog |
78 |
0.91 |
chr2_27411040_27411199 | 1.17 |
Gm24049 |
predicted gene, 24049 |
9267 |
0.14 |
chr11_117978177_117978328 | 1.16 |
Pgs1 |
phosphatidylglycerophosphate synthase 1 |
8040 |
0.14 |
chr5_114962194_114962345 | 1.15 |
Hnf1aos1 |
HNF1 homeobox A, opposite strand 1 |
6515 |
0.09 |
chr2_165356981_165357132 | 1.15 |
Zfp663 |
zinc finger protein 663 |
2345 |
0.22 |
chr11_85833878_85836704 | 1.15 |
Tbx2 |
T-box 2 |
2740 |
0.17 |
chr2_172675176_172675327 | 1.15 |
Tfap2c |
transcription factor AP-2, gamma |
123135 |
0.05 |
chr12_57547954_57550746 | 1.14 |
Foxa1 |
forkhead box A1 |
2434 |
0.23 |
chr4_149945157_149945448 | 1.14 |
Spsb1 |
splA/ryanodine receptor domain and SOCS box containing 1 |
796 |
0.6 |
chr5_111639366_111640356 | 1.14 |
Gm42489 |
predicted gene 42489 |
46245 |
0.13 |
chr4_83050960_83052655 | 1.14 |
Frem1 |
Fras1 related extracellular matrix protein 1 |
360 |
0.89 |
chr4_141297791_141297942 | 1.14 |
Epha2 |
Eph receptor A2 |
3374 |
0.14 |
chr17_47686417_47686696 | 1.14 |
Tomm6os |
translocase of outer mitochondrial membrane 6, opposite strand |
1054 |
0.25 |
chr18_11076781_11076932 | 1.13 |
Gata6 |
GATA binding protein 6 |
17809 |
0.21 |
chr5_128600778_128602300 | 1.13 |
Fzd10 |
frizzled class receptor 10 |
695 |
0.45 |
chr5_148689648_148690655 | 1.13 |
Gm36186 |
predicted gene, 36186 |
21315 |
0.16 |
chr7_48964377_48965190 | 1.13 |
Nav2 |
neuron navigator 2 |
5686 |
0.18 |
chr15_97761199_97761350 | 1.11 |
Rapgef3 |
Rap guanine nucleotide exchange factor (GEF) 3 |
580 |
0.5 |
chr12_86881882_86884741 | 1.11 |
Irf2bpl |
interferon regulatory factor 2 binding protein-like |
1487 |
0.4 |
chr4_44711553_44714511 | 1.11 |
Pax5 |
paired box 5 |
2545 |
0.22 |
chr11_120613752_120613989 | 1.11 |
Pcyt2 |
phosphate cytidylyltransferase 2, ethanolamine |
175 |
0.82 |
chr4_133665539_133665690 | 1.11 |
Pigv |
phosphatidylinositol glycan anchor biosynthesis, class V |
7033 |
0.13 |
chr4_154652555_154652706 | 1.10 |
Gm13110 |
predicted gene 13110 |
2688 |
0.18 |
chr1_163308490_163310681 | 1.09 |
Gm37644 |
predicted gene, 37644 |
518 |
0.77 |
chr2_167539777_167540513 | 1.08 |
Snai1 |
snail family zinc finger 1 |
1950 |
0.22 |
chr10_77190994_77191683 | 1.08 |
Col18a1 |
collagen, type XVIII, alpha 1 |
24790 |
0.16 |
chr10_81399588_81399739 | 1.08 |
Nfic |
nuclear factor I/C |
891 |
0.27 |
chr1_184731287_184732512 | 1.08 |
Hlx |
H2.0-like homeobox |
301 |
0.86 |
chr3_89136417_89137539 | 1.07 |
Pklr |
pyruvate kinase liver and red blood cell |
355 |
0.69 |
chr15_103038687_103039944 | 1.06 |
Hoxc4 |
homeobox C4 |
4920 |
0.1 |
chr19_16875307_16877159 | 1.06 |
Foxb2 |
forkhead box B2 |
2428 |
0.3 |
chr1_193507248_193508338 | 1.06 |
Mir205 |
microRNA 205 |
263 |
0.89 |
chr13_54577114_54577265 | 1.06 |
Gm24195 |
predicted gene, 24195 |
924 |
0.32 |
chr2_28082211_28082472 | 1.06 |
Fcnb |
ficolin B |
2544 |
0.24 |
chr5_123018560_123018998 | 1.05 |
Orai1 |
ORAI calcium release-activated calcium modulator 1 |
3441 |
0.11 |
chr4_83049376_83049621 | 1.05 |
Frem1 |
Fras1 related extracellular matrix protein 1 |
2669 |
0.31 |
chr17_27041083_27041234 | 1.05 |
Ggnbp1 |
gametogenetin binding protein 1 |
8299 |
0.09 |
chr3_104734601_104734752 | 1.04 |
Gm6485 |
predicted gene 6485 |
18489 |
0.09 |
chr5_32153164_32153923 | 1.04 |
Fosl2 |
fos-like antigen 2 |
7022 |
0.15 |
chr4_150028726_150028888 | 1.04 |
H6pd |
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
19784 |
0.11 |
chr14_28514085_28515337 | 1.04 |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
3260 |
0.25 |
chr19_4217053_4217761 | 1.03 |
Gm26115 |
predicted gene, 26115 |
1919 |
0.1 |
chr9_108575675_108576275 | 1.03 |
Wdr6 |
WD repeat domain 6 |
2764 |
0.07 |
chr9_107616495_107616646 | 1.02 |
Gnai2 |
guanine nucleotide binding protein (G protein), alpha inhibiting 2 |
58 |
0.91 |
chr11_104724843_104724994 | 1.02 |
Gm11639 |
predicted gene 11639 |
20560 |
0.18 |
chr5_23781267_23781467 | 1.02 |
Pus7 |
pseudouridylate synthase 7 |
1809 |
0.2 |
chr5_113799288_113800716 | 1.02 |
Tmem119 |
transmembrane protein 119 |
444 |
0.69 |
chr7_98354101_98355234 | 1.01 |
Tsku |
tsukushi, small leucine rich proteoglycan |
5412 |
0.19 |
chr12_107954616_107954767 | 1.01 |
Bcl11b |
B cell leukemia/lymphoma 11B |
48723 |
0.17 |
chr5_99944026_99944275 | 1.01 |
Gm22838 |
predicted gene, 22838 |
15769 |
0.13 |
chr5_112282231_112282505 | 1.01 |
Tpst2 |
protein-tyrosine sulfotransferase 2 |
5661 |
0.13 |
chr4_135859431_135860428 | 1.01 |
Srsf10 |
serine and arginine-rich splicing factor 10 |
1859 |
0.21 |
chr8_105308552_105308703 | 1.01 |
Mir328 |
microRNA 328 |
167 |
0.77 |
chr11_33202043_33204837 | 1.00 |
Tlx3 |
T cell leukemia, homeobox 3 |
149 |
0.86 |
chr14_52310870_52313267 | 1.00 |
Sall2 |
spalt like transcription factor 2 |
4255 |
0.1 |
chr2_27469062_27470641 | 0.99 |
Brd3 |
bromodomain containing 3 |
5269 |
0.15 |
chr9_74864280_74865379 | 0.99 |
Onecut1 |
one cut domain, family member 1 |
1655 |
0.3 |
chr12_109452854_109454456 | 0.99 |
Dlk1 |
delta like non-canonical Notch ligand 1 |
0 |
0.96 |
chr6_126002989_126003161 | 0.98 |
Gm24947 |
predicted gene, 24947 |
118660 |
0.06 |
chr11_116080051_116080222 | 0.97 |
Wbp2 |
WW domain binding protein 2 |
1349 |
0.25 |
chr8_105520321_105521493 | 0.97 |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
2152 |
0.16 |
chr8_23053368_23054164 | 0.96 |
Ank1 |
ankyrin 1, erythroid |
4493 |
0.2 |
chr19_6955564_6955849 | 0.95 |
Plcb3 |
phospholipase C, beta 3 |
109 |
0.9 |
chr17_26204162_26204508 | 0.95 |
Rgs11 |
regulator of G-protein signaling 11 |
1323 |
0.2 |
chr5_74064229_74066220 | 0.95 |
Usp46 |
ubiquitin specific peptidase 46 |
524 |
0.65 |
chr5_146789694_146789910 | 0.94 |
Usp12 |
ubiquitin specific peptidase 12 |
5204 |
0.15 |
chr7_140950318_140950619 | 0.94 |
Ifitm5 |
interferon induced transmembrane protein 5 |
177 |
0.85 |
chr16_18418877_18419232 | 0.94 |
Gm15764 |
predicted gene 15764 |
2169 |
0.17 |
chr5_128602323_128602997 | 0.93 |
Fzd10 |
frizzled class receptor 10 |
1816 |
0.25 |
chr12_109608051_109608475 | 0.93 |
Rian |
RNA imprinted and accumulated in nucleus |
799 |
0.15 |
chr5_37821115_37822599 | 0.93 |
Msx1 |
msh homeobox 1 |
2725 |
0.28 |
chr6_52258879_52259437 | 0.93 |
Hoxa13 |
homeobox A13 |
1644 |
0.13 |
chr5_125110834_125110985 | 0.93 |
Ncor2 |
nuclear receptor co-repressor 2 |
13991 |
0.18 |
chr4_124605630_124606127 | 0.93 |
4933407E24Rik |
RIKEN cDNA 4933407E24 gene |
36688 |
0.11 |
chr4_154630838_154632339 | 0.92 |
Prdm16 |
PR domain containing 16 |
5209 |
0.14 |
chr8_107545084_107547731 | 0.92 |
Wwp2 |
WW domain containing E3 ubiquitin protein ligase 2 |
1395 |
0.4 |
chr15_97223953_97224176 | 0.91 |
Pced1b |
PC-esterase domain containing 1B |
23043 |
0.18 |
chr8_92960352_92961533 | 0.91 |
Slc6a2 |
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
9 |
0.97 |
chr2_168048218_168048408 | 0.91 |
Gm24327 |
predicted gene, 24327 |
16584 |
0.13 |
chr15_103026302_103028215 | 0.91 |
Hoxc4 |
homeobox C4 |
7137 |
0.09 |
chr7_96643662_96644951 | 0.91 |
Tenm4 |
teneurin transmembrane protein 4 |
134 |
0.97 |
chr3_122111716_122112097 | 0.90 |
Abca4 |
ATP-binding cassette, sub-family A (ABC1), member 4 |
8134 |
0.18 |
chr2_26390502_26391237 | 0.90 |
Pmpca |
peptidase (mitochondrial processing) alpha |
58 |
0.92 |
chr6_113434475_113434733 | 0.90 |
Cidec |
cell death-inducing DFFA-like effector c |
9 |
0.93 |
chr16_21074560_21074848 | 0.90 |
Gm9697 |
predicted gene 9697 |
4966 |
0.17 |
chr2_9882196_9886301 | 0.89 |
9230102O04Rik |
RIKEN cDNA 9230102O04 gene |
255 |
0.84 |
chr2_165597106_165597991 | 0.89 |
Eya2 |
EYA transcriptional coactivator and phosphatase 2 |
2516 |
0.26 |
chr11_102631042_102631688 | 0.89 |
2810433D01Rik |
RIKEN cDNA 2810433D01 gene |
6949 |
0.1 |
chr8_70329770_70331438 | 0.89 |
Gdf1 |
growth differentiation factor 1 |
787 |
0.45 |
chr5_143311853_143312278 | 0.88 |
Gm42501 |
predicted gene 42501 |
2774 |
0.11 |
chr15_77214359_77214956 | 0.88 |
Rbfox2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
11221 |
0.15 |
chr19_5111723_5111973 | 0.88 |
Klc2 |
kinesin light chain 2 |
136 |
0.88 |
chr8_92362973_92364962 | 0.88 |
Irx5 |
Iroquois homeobox 5 |
6218 |
0.19 |
chr10_61826976_61827127 | 0.88 |
Col13a1 |
collagen, type XIII, alpha 1 |
22160 |
0.16 |
chr11_70641761_70641932 | 0.87 |
Gp1ba |
glycoprotein 1b, alpha polypeptide |
2702 |
0.09 |
chr8_70491791_70492394 | 0.87 |
Crlf1 |
cytokine receptor-like factor 1 |
1066 |
0.28 |
chr16_92695033_92696333 | 0.86 |
Runx1 |
runt related transcription factor 1 |
188 |
0.96 |
chr6_52211753_52213405 | 0.86 |
Hoxa3 |
homeobox A3 |
536 |
0.36 |
chr7_29338848_29339244 | 0.86 |
Sipa1l3 |
signal-induced proliferation-associated 1 like 3 |
17 |
0.97 |
chr3_49753928_49755610 | 0.85 |
Pcdh18 |
protocadherin 18 |
695 |
0.72 |
chr8_25542987_25545804 | 0.85 |
Gm16159 |
predicted gene 16159 |
9165 |
0.11 |
chr12_113071223_113071374 | 0.85 |
Pacs2 |
phosphofurin acidic cluster sorting protein 2 |
626 |
0.56 |
chr5_136246095_136246484 | 0.84 |
Sh2b2 |
SH2B adaptor protein 2 |
267 |
0.88 |
chr4_117097970_117098873 | 0.84 |
Ptch2 |
patched 2 |
2325 |
0.13 |
chr17_35104033_35104957 | 0.84 |
Abhd16a |
abhydrolase domain containing 16A |
3641 |
0.05 |
chr1_177518334_177518570 | 0.83 |
Gm37306 |
predicted gene, 37306 |
51074 |
0.11 |
chr7_139299432_139299640 | 0.83 |
Gm32486 |
predicted gene, 32486 |
2671 |
0.26 |
chr7_98158948_98159132 | 0.83 |
Capn5 |
calpain 5 |
3170 |
0.19 |
chr9_114548190_114548572 | 0.83 |
Trim71 |
tripartite motif-containing 71 |
15988 |
0.15 |
chr17_33778675_33780469 | 0.83 |
Angptl4 |
angiopoietin-like 4 |
429 |
0.65 |
chr3_99240695_99241824 | 0.82 |
Tbx15 |
T-box 15 |
878 |
0.53 |
chr3_99261050_99262399 | 0.82 |
Gm43120 |
predicted gene 43120 |
439 |
0.81 |
chr4_134365567_134365718 | 0.82 |
Extl1 |
exostosin-like glycosyltransferase 1 |
218 |
0.89 |
chr11_70640695_70640978 | 0.82 |
Gp1ba |
glycoprotein 1b, alpha polypeptide |
1692 |
0.13 |
chr5_142529665_142530316 | 0.82 |
Papolb |
poly (A) polymerase beta (testis specific) |
86 |
0.96 |
chr1_162217585_162219370 | 0.81 |
Dnm3os |
dynamin 3, opposite strand |
601 |
0.46 |
chr2_109693096_109694906 | 0.81 |
Bdnf |
brain derived neurotrophic factor |
408 |
0.85 |
chr11_69364290_69367679 | 0.80 |
Chd3 |
chromodomain helicase DNA binding protein 3 |
1205 |
0.24 |
chr13_55830047_55831334 | 0.80 |
Pitx1 |
paired-like homeodomain transcription factor 1 |
735 |
0.57 |
chr15_77976634_77976983 | 0.79 |
Eif3d |
eukaryotic translation initiation factor 3, subunit D |
5995 |
0.16 |
chr2_156840101_156841614 | 0.79 |
Tgif2 |
TGFB-induced factor homeobox 2 |
165 |
0.85 |
chr3_89142017_89142261 | 0.79 |
Pklr |
pyruvate kinase liver and red blood cell |
5516 |
0.07 |
chr10_127341028_127341996 | 0.79 |
Gli1 |
GLI-Kruppel family member GLI1 |
374 |
0.69 |
chr8_34079766_34081014 | 0.79 |
Dctn6 |
dynactin 6 |
12535 |
0.12 |
chr2_122237098_122237979 | 0.79 |
Sord |
sorbitol dehydrogenase |
2789 |
0.15 |
chr13_91461118_91462460 | 0.78 |
Ssbp2 |
single-stranded DNA binding protein 2 |
608 |
0.81 |
chr11_69908575_69909064 | 0.78 |
Neurl4 |
neuralized E3 ubiquitin protein ligase 4 |
157 |
0.84 |
chr19_6053731_6054284 | 0.78 |
AC131692.1 |
mitochondrial ribosomal protein L49 (Mrpl49) pseudogene |
1659 |
0.1 |
chr15_51628741_51628892 | 0.78 |
Gm34562 |
predicted gene, 34562 |
819 |
0.74 |
chr2_109677166_109678631 | 0.77 |
Bdnf |
brain derived neurotrophic factor |
866 |
0.48 |
chr6_52247829_52249819 | 0.77 |
Hoxa11os |
homeobox A11, opposite strand |
402 |
0.59 |
chr8_123105398_123105550 | 0.77 |
Mir7079 |
microRNA 7079 |
499 |
0.56 |
chr11_96347886_96350398 | 0.77 |
Hoxb3os |
homeobox B3 and homeobox B2, opposite strand |
1219 |
0.21 |
chr4_114903163_114903314 | 0.76 |
9130410C08Rik |
RIKEN cDNA 9130410C08 gene |
379 |
0.8 |
chr11_117349733_117350405 | 0.76 |
Septin9 |
septin 9 |
3111 |
0.25 |
chr11_79054570_79054867 | 0.76 |
Ksr1 |
kinase suppressor of ras 1 |
2909 |
0.27 |
chr4_134934099_134934393 | 0.75 |
Syf2 |
SYF2 homolog, RNA splicing factor (S. cerevisiae) |
3236 |
0.21 |
chr11_109517775_109517926 | 0.75 |
Gm22378 |
predicted gene, 22378 |
18026 |
0.13 |
chr17_25724402_25724698 | 0.75 |
Chtf18 |
CTF18, chromosome transmission fidelity factor 18 |
2806 |
0.08 |
chr11_120257057_120257435 | 0.75 |
Gm47297 |
predicted gene, 47297 |
17241 |
0.09 |
chr8_119438798_119439203 | 0.74 |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
1811 |
0.28 |
chr2_34774288_34775191 | 0.74 |
Hspa5 |
heat shock protein 5 |
108 |
0.95 |
chr6_52233543_52234485 | 0.74 |
Hoxa10 |
homeobox A10 |
690 |
0.34 |
chr9_107702308_107702459 | 0.74 |
Sema3f |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
3173 |
0.12 |
chr17_56286695_56286846 | 0.74 |
Plin3 |
perilipin 3 |
3741 |
0.11 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.6 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.6 | 2.6 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.6 | 1.7 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.6 | 0.6 | GO:0010159 | specification of organ position(GO:0010159) |
0.5 | 1.6 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.5 | 1.0 | GO:0021564 | vagus nerve development(GO:0021564) |
0.4 | 1.3 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.4 | 1.3 | GO:0072050 | S-shaped body morphogenesis(GO:0072050) |
0.4 | 0.4 | GO:0060435 | bronchiole development(GO:0060435) |
0.4 | 1.6 | GO:0007494 | midgut development(GO:0007494) |
0.4 | 1.2 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.4 | 1.5 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.4 | 1.1 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.4 | 0.4 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.4 | 1.1 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.4 | 1.8 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.3 | 1.0 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.3 | 1.0 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
0.3 | 1.0 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.3 | 2.9 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.3 | 0.9 | GO:0060594 | mammary gland specification(GO:0060594) |
0.3 | 0.9 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.3 | 1.2 | GO:0007412 | axon target recognition(GO:0007412) |
0.3 | 0.8 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.3 | 1.1 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.3 | 1.0 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 1.3 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.2 | 0.9 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.2 | 0.9 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.2 | 0.4 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.2 | 0.6 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.2 | 0.6 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.2 | 0.8 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 0.4 | GO:0072162 | paramesonephric duct development(GO:0061205) metanephric mesenchymal cell differentiation(GO:0072162) |
0.2 | 1.2 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.2 | 1.5 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.2 | 1.9 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 0.6 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.2 | 0.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 0.6 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.2 | 0.7 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.2 | 0.4 | GO:0060596 | mammary placode formation(GO:0060596) |
0.2 | 0.4 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.2 | 0.4 | GO:0061183 | dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
0.2 | 1.6 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 0.5 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.2 | 0.7 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.2 | 1.2 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.2 | 0.9 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.2 | 0.5 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.2 | 0.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 1.0 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.2 | 0.7 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.2 | 0.9 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.2 | 0.5 | GO:1904746 | negative regulation of apoptotic process involved in development(GO:1904746) |
0.2 | 0.7 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.2 | 0.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.2 | 0.5 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.2 | 0.5 | GO:0097503 | sialylation(GO:0097503) |
0.2 | 0.3 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
0.2 | 0.8 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.2 | 1.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.2 | 0.5 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.2 | 0.5 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.2 | 0.3 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.2 | 0.8 | GO:0061525 | hindgut development(GO:0061525) |
0.2 | 0.3 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.2 | 0.6 | GO:0035989 | tendon development(GO:0035989) |
0.2 | 0.2 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.2 | 0.5 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
0.2 | 2.3 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.2 | 0.9 | GO:0072044 | collecting duct development(GO:0072044) |
0.2 | 0.5 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.2 | 1.4 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 0.8 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.2 | 0.6 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.1 | 0.6 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.1 | 0.4 | GO:1905049 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.1 | 0.6 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.1 | 0.3 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.1 | 0.4 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.9 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.3 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.1 | 3.0 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.1 | 0.4 | GO:1902075 | cellular response to salt(GO:1902075) |
0.1 | 0.4 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.1 | 0.1 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
0.1 | 0.4 | GO:0061511 | centriole elongation(GO:0061511) |
0.1 | 0.3 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.1 | 0.4 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.1 | 0.4 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.1 | 0.4 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.1 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.1 | 0.1 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.1 | 0.1 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.8 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.1 | 0.1 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.1 | 0.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 1.8 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.6 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 6.2 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.1 | 0.4 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 0.1 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.1 | 0.5 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.1 | 0.6 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.2 | GO:0045764 | positive regulation of cellular amino acid metabolic process(GO:0045764) |
0.1 | 0.2 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.1 | 1.1 | GO:1902003 | regulation of beta-amyloid formation(GO:1902003) |
0.1 | 0.6 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.1 | 0.4 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.1 | 0.8 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 0.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.1 | 0.4 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.1 | 0.2 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.1 | 0.2 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 0.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.1 | 0.3 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.7 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.3 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.1 | 0.2 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.1 | 0.6 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 0.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 2.3 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.1 | 0.3 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.1 | 0.2 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.1 | 0.2 | GO:0048880 | sensory system development(GO:0048880) |
0.1 | 0.3 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.1 | 0.5 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 0.1 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.1 | 0.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.5 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.2 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.4 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.1 | 0.3 | GO:0009750 | response to fructose(GO:0009750) |
0.1 | 0.5 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 0.2 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.1 | 0.4 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.1 | 0.3 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 1.0 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.3 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.1 | 0.2 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
0.1 | 0.4 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 0.3 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.1 | 0.6 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.2 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.1 | 0.2 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.1 | 0.6 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.1 | 0.9 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 0.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.1 | 0.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 0.2 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.1 | 0.4 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.1 | 0.3 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 1.1 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.1 | 0.3 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.1 | 0.8 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.1 | 0.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.3 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.1 | 0.2 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 0.3 | GO:0072079 | nephron tubule formation(GO:0072079) |
0.1 | 0.9 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.1 | 0.1 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.1 | 0.5 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.3 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.6 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.5 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 0.8 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 0.4 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.2 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.1 | 0.5 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.3 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.4 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.1 | 0.3 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.1 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.1 | 0.9 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.1 | 0.3 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.1 | 0.2 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.1 | 0.1 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.1 | 0.1 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.1 | 0.3 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 0.3 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 0.6 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 1.0 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.1 | 0.3 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.1 | 0.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.4 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 0.3 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.1 | 0.2 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.1 | 0.3 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
0.1 | 0.3 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.4 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.1 | 0.2 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.1 | 0.4 | GO:0070627 | ferrous iron import(GO:0070627) |
0.1 | 0.5 | GO:0060770 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.2 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.1 | 0.3 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 0.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.6 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.2 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.1 | 1.3 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.2 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 0.2 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.8 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.1 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.1 | 0.2 | GO:0045472 | response to ether(GO:0045472) |
0.1 | 0.1 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.1 | 0.2 | GO:0021586 | pons maturation(GO:0021586) |
0.1 | 0.2 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 0.5 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.1 | 0.1 | GO:0032898 | neurotrophin production(GO:0032898) |
0.1 | 1.5 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.1 | 0.3 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.1 | 0.3 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.1 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 1.5 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.2 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.1 | 0.1 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.1 | 0.1 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.1 | 0.3 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 0.2 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.1 | 0.3 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.1 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.2 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.1 | 0.5 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.1 | 0.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.1 | 0.2 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.1 | 0.3 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.2 | GO:0046066 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.1 | 0.4 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.1 | 0.1 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.5 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.1 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.1 | 0.1 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.9 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 0.2 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.1 | 0.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.1 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.1 | 0.2 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.4 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.2 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.1 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.1 | 0.5 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.1 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.1 | 0.3 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.1 | 0.2 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.1 | 0.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 1.5 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.5 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 0.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.9 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.2 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.1 | 0.3 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 0.2 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.3 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.1 | 0.1 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.1 | 0.6 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.2 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.1 | 0.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.1 | 0.3 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.1 | 1.4 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.1 | 0.1 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.1 | 0.2 | GO:0035588 | G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.1 | 0.1 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.1 | 0.1 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.1 | 0.3 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 0.2 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.1 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.1 | 0.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.1 | 0.2 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.1 | 0.1 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 0.1 | GO:0006868 | glutamine transport(GO:0006868) |
0.1 | 0.1 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.1 | 0.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.2 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.1 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.1 | 0.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 1.0 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 0.1 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.1 | 0.1 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 0.1 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.1 | 0.2 | GO:2000739 | regulation of mesenchymal stem cell differentiation(GO:2000739) |
0.1 | 0.2 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.4 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.1 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.1 | 0.1 | GO:0061196 | fungiform papilla development(GO:0061196) |
0.1 | 0.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.1 | GO:0003129 | heart induction(GO:0003129) |
0.1 | 0.1 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.1 | 0.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 0.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.1 | GO:0002432 | granuloma formation(GO:0002432) |
0.1 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.2 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 0.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.2 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.1 | 0.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.1 | 0.3 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.1 | 0.3 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.2 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.1 | 0.4 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 0.9 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.2 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.1 | 0.3 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 0.1 | GO:0040031 | snRNA modification(GO:0040031) |
0.1 | 0.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.2 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.1 | 0.1 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 0.1 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.1 | 0.1 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.1 | 0.1 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.1 | 0.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.1 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.1 | 0.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.2 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 0.2 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 0.1 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
0.1 | 0.3 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 0.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.1 | 0.1 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.1 | 0.1 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.1 | 0.1 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.1 | 0.3 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.1 | 0.5 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.2 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 0.1 | GO:1901339 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.2 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.2 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.1 | 0.6 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.1 | 0.1 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.1 | 0.1 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.1 | 0.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.1 | GO:0060534 | trachea cartilage development(GO:0060534) |
0.1 | 0.3 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.1 | GO:0090500 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) endocardial cushion to mesenchymal transition(GO:0090500) |
0.1 | 0.3 | GO:0032925 | regulation of activin receptor signaling pathway(GO:0032925) |
0.1 | 0.2 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.2 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.1 | 0.1 | GO:0061724 | lipophagy(GO:0061724) |
0.1 | 0.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.0 | 0.2 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
0.0 | 0.1 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.0 | 0.0 | GO:0072038 | mesenchymal stem cell maintenance involved in nephron morphogenesis(GO:0072038) |
0.0 | 0.1 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.0 | 0.1 | GO:1901656 | glycoside transport(GO:1901656) |
0.0 | 0.7 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.0 | GO:0060525 | prostate glandular acinus development(GO:0060525) |
0.0 | 0.6 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.0 | 0.1 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.0 | 0.1 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.0 | 0.2 | GO:0044838 | cell quiescence(GO:0044838) |
0.0 | 0.7 | GO:0009299 | mRNA transcription(GO:0009299) |
0.0 | 0.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.0 | 0.1 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.0 | 0.1 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 0.0 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.0 | 0.0 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.0 | 0.2 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.2 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.0 | 0.1 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.0 | 0.3 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.2 | GO:1904970 | brush border assembly(GO:1904970) |
0.0 | 0.1 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
0.0 | 0.1 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.0 | 0.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.1 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
0.0 | 0.3 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.0 | 0.3 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.0 | 0.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.0 | 0.0 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.0 | 0.1 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.0 | 0.4 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.2 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.0 | 0.2 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.0 | 0.1 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.0 | 0.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.0 | 0.1 | GO:0042938 | dipeptide transport(GO:0042938) |
0.0 | 0.1 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.0 | 0.1 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.0 | 0.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.0 | 0.0 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 0.2 | GO:0061042 | vascular wound healing(GO:0061042) |
0.0 | 0.0 | GO:0042891 | antibiotic transport(GO:0042891) |
0.0 | 0.4 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.0 | 1.0 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.3 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.1 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.0 | 0.2 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.0 | 0.1 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.0 | 0.4 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.2 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.0 | 0.4 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.3 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.9 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.4 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.2 | GO:0060253 | negative regulation of glial cell proliferation(GO:0060253) |
0.0 | 0.1 | GO:0010288 | response to lead ion(GO:0010288) |
0.0 | 0.0 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.0 | 0.0 | GO:1903367 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.0 | 0.3 | GO:0036093 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
0.0 | 0.2 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.1 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.0 | 0.1 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.0 | 0.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.1 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.0 | 0.3 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.0 | 0.7 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.0 | 0.0 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.0 | 0.1 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.0 | 0.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.0 | 0.1 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.0 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.1 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.0 | 0.0 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.0 | 0.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.0 | 0.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.0 | 0.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.0 | 0.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.0 | 0.1 | GO:0033121 | regulation of purine nucleotide catabolic process(GO:0033121) |
0.0 | 0.2 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.0 | 0.3 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.2 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.2 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.0 | 0.0 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.0 | 0.0 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 0.2 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.0 | 0.1 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.0 | 0.3 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.0 | 0.0 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
0.0 | 0.2 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.0 | 0.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.1 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.0 | 0.1 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.0 | 0.2 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.0 | 0.0 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.0 | 0.1 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.0 | 0.3 | GO:0031274 | regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.1 | GO:0032202 | telomere assembly(GO:0032202) |
0.0 | 0.4 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.2 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.0 | 0.1 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.0 | 0.1 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.0 | 0.0 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.0 | 0.1 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.0 | 0.1 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.1 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.0 | 0.3 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.0 | 0.1 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 0.3 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.0 | 0.1 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.0 | 0.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) bile acid secretion(GO:0032782) |
0.0 | 0.1 | GO:0097421 | liver regeneration(GO:0097421) |
0.0 | 0.3 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.0 | 0.1 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.0 | 0.1 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.0 | 0.2 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.0 | 0.3 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.0 | 0.2 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.0 | 0.1 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.0 | 0.1 | GO:2000647 | negative regulation of stem cell proliferation(GO:2000647) |
0.0 | 0.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 0.1 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.1 | GO:0031620 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) |
0.0 | 0.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.2 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.0 | 0.4 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.0 | 0.1 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.0 | 0.1 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.0 | 0.1 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.0 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.0 | 0.2 | GO:0030575 | nuclear body organization(GO:0030575) |
0.0 | 0.1 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.0 | 0.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.4 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.0 | 0.0 | GO:0042504 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.0 | 0.5 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.0 | 0.0 | GO:0061548 | ganglion development(GO:0061548) |
0.0 | 0.1 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.0 | 0.5 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.0 | 0.1 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.0 | 0.5 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.0 | 0.2 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.1 | GO:0046016 | positive regulation of transcription by glucose(GO:0046016) |
0.0 | 0.4 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.0 | 0.1 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.0 | 0.2 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.0 | 0.1 | GO:0072178 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.0 | 0.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.0 | 0.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.3 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.3 | GO:1901072 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.0 | GO:0045188 | regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
0.0 | 0.1 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.0 | 0.4 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.1 | GO:2000002 | negative regulation of cell cycle checkpoint(GO:1901977) negative regulation of DNA damage checkpoint(GO:2000002) |
0.0 | 0.0 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.0 | 0.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.0 | 0.1 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.0 | 0.0 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.0 | 0.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.1 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.0 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.0 | 0.2 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 0.3 | GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) |
0.0 | 0.1 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.0 | 0.2 | GO:0001893 | maternal placenta development(GO:0001893) |
0.0 | 0.2 | GO:0042048 | olfactory behavior(GO:0042048) |
0.0 | 0.3 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.0 | 0.3 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.1 | GO:0031446 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.0 | 0.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.0 | 0.0 | GO:0032252 | secretory granule localization(GO:0032252) |
0.0 | 0.3 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.0 | 0.4 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.5 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.0 | 0.6 | GO:1904292 | regulation of ERAD pathway(GO:1904292) |
0.0 | 0.1 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 | 0.1 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.0 | 0.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.0 | 0.2 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.0 | 0.1 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.0 | 0.2 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.0 | 0.4 | GO:0030574 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
0.0 | 0.1 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.0 | 0.3 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.0 | 0.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 1.0 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 0.2 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.0 | 0.5 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.0 | 0.0 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.0 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.2 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.0 | 0.0 | GO:0001794 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.0 | 0.3 | GO:0060713 | labyrinthine layer morphogenesis(GO:0060713) |
0.0 | 0.1 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.0 | 0.1 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.0 | 0.0 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.9 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.0 | 0.0 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) |
0.0 | 0.2 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.3 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.0 | 0.0 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.1 | GO:1901838 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.0 | 0.1 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.0 | 0.1 | GO:0007350 | blastoderm segmentation(GO:0007350) |
0.0 | 1.2 | GO:0030282 | bone mineralization(GO:0030282) |
0.0 | 0.2 | GO:0010954 | positive regulation of protein processing(GO:0010954) |
0.0 | 0.8 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.0 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.0 | 0.0 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.0 | 0.2 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.0 | 0.0 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.0 | 0.1 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.0 | 0.1 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.1 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.0 | 0.1 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.0 | 0.2 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.0 | 0.0 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.0 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.0 | GO:0072173 | metanephric tubule morphogenesis(GO:0072173) |
0.0 | 0.1 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.0 | 0.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.0 | 0.1 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 0.0 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.0 | 0.0 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.0 | 0.0 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.0 | 0.4 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.0 | 0.1 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.0 | 0.1 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.0 | 0.3 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.0 | GO:0033026 | negative regulation of mast cell apoptotic process(GO:0033026) |
0.0 | 0.2 | GO:0050779 | RNA destabilization(GO:0050779) |
0.0 | 0.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 0.1 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.0 | 0.0 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.2 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.1 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.0 | 0.2 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.1 | GO:0032196 | transposition(GO:0032196) |
0.0 | 0.1 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.0 | 0.1 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.2 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.0 | 0.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.2 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.1 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.0 | 0.3 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 0.4 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.6 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.0 | 0.1 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.0 | 0.1 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.0 | 0.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.0 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 0.1 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.2 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.0 | 0.0 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.0 | 0.2 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.0 | 0.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.0 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.0 | 0.1 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.0 | 0.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.0 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.0 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.0 | 0.2 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.0 | 0.1 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.0 | 0.0 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.1 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.0 | 0.0 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.0 | 0.0 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.0 | 0.1 | GO:0001842 | neural fold formation(GO:0001842) |
0.0 | 0.1 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.0 | 0.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.0 | 0.0 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.0 | 0.2 | GO:1903541 | regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
0.0 | 0.3 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.0 | 0.0 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.0 | 0.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.2 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.1 | GO:0007128 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.0 | 0.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.2 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.1 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.0 | 0.0 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.0 | 0.6 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.1 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.0 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.1 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.0 | 0.0 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.0 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.0 | GO:1903044 | protein localization to membrane raft(GO:1903044) |
0.0 | 0.1 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.0 | 0.2 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.2 | GO:0043486 | histone exchange(GO:0043486) |
0.0 | 0.1 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.0 | 0.0 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.0 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.0 | 0.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.0 | 0.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.0 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.0 | 0.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.1 | GO:0070836 | caveola assembly(GO:0070836) |
0.0 | 0.1 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.0 | 0.0 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.0 | 0.3 | GO:0035108 | appendage morphogenesis(GO:0035107) limb morphogenesis(GO:0035108) |
0.0 | 0.2 | GO:0042730 | fibrinolysis(GO:0042730) |
0.0 | 0.0 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.0 | 0.1 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.0 | 0.0 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.0 | 0.1 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.0 | 0.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.1 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.0 | 0.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 0.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.0 | 0.1 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.3 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.0 | 0.2 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.0 | 0.1 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.0 | 0.0 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 0.3 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.0 | 0.0 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.0 | 0.7 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.1 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.0 | 0.1 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.0 | 0.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.0 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.0 | 0.0 | GO:0002606 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.0 | 0.2 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.1 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
0.0 | 0.0 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.0 | 0.0 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.0 | 0.3 | GO:0034340 | response to type I interferon(GO:0034340) |
0.0 | 0.1 | GO:0034104 | negative regulation of tissue remodeling(GO:0034104) |
0.0 | 0.1 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.0 | 0.0 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.0 | 0.3 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.0 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.0 | 0.1 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.0 | 0.2 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
0.0 | 0.0 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.0 | 0.1 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.0 | 0.0 | GO:0051135 | positive regulation of NK T cell activation(GO:0051135) |
0.0 | 0.0 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.0 | 0.0 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
0.0 | 0.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.0 | 0.0 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.0 | 0.1 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.0 | 0.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.0 | 0.0 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.0 | 0.1 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.0 | 0.1 | GO:0036035 | osteoclast development(GO:0036035) |
0.0 | 0.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.0 | 0.1 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.0 | 0.0 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.1 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.0 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.0 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.0 | 0.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.0 | 0.6 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.0 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 0.0 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.0 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.1 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.0 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.0 | 0.0 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.0 | 0.0 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.0 | 0.0 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.0 | 0.4 | GO:0006378 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.0 | 0.1 | GO:0060068 | vagina development(GO:0060068) |
0.0 | 0.1 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.0 | 0.0 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.0 | 0.0 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.0 | 0.0 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.0 | 0.1 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.0 | 0.0 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.0 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) rRNA transport(GO:0051029) |
0.0 | 0.0 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
0.0 | 0.1 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.0 | 0.0 | GO:0043584 | nose development(GO:0043584) |
0.0 | 0.2 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.0 | 0.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.1 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.0 | 0.3 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.0 | GO:0045655 | regulation of monocyte differentiation(GO:0045655) positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.0 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.1 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.0 | 0.1 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.0 | 0.0 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.1 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.0 | 0.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.0 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.0 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.0 | 0.2 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.0 | 0.0 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.0 | 0.0 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
0.0 | 0.0 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.1 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.0 | 0.0 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.3 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.4 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.0 | 0.0 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.0 | 0.0 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.0 | 0.0 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.0 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.0 | 0.0 | GO:0072395 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.0 | 0.1 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.1 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 0.2 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.0 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.1 | GO:0032329 | serine transport(GO:0032329) |
0.0 | 0.0 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.0 | 0.1 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
0.0 | 0.0 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.0 | 0.0 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.1 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.0 | 0.0 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.1 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.0 | 0.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.1 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
0.0 | 0.0 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.0 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.0 | 0.0 | GO:0015840 | urea transport(GO:0015840) |
0.0 | 0.1 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.0 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.0 | 0.0 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.0 | 0.0 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.0 | 0.0 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.0 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.0 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.0 | 0.1 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.0 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.0 | 0.0 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.0 | 0.0 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.1 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.0 | 0.0 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.0 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.0 | 0.0 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.0 | 0.1 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.0 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.0 | 0.0 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.1 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.0 | 0.0 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.0 | 0.0 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.0 | 0.0 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.0 | 0.0 | GO:2000644 | regulation of receptor catabolic process(GO:2000644) |
0.0 | 0.0 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.0 | 0.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.0 | GO:0070197 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.0 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.0 | 0.0 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.0 | 0.0 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.0 | 0.0 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.0 | 0.0 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.0 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.0 | 0.0 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.0 | 0.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.0 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.0 | 0.0 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.0 | GO:0006189 | IMP biosynthetic process(GO:0006188) 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.0 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.0 | 0.0 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.0 | 0.1 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.1 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.0 | 1.3 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.0 | 0.3 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.0 | 0.1 | GO:0051904 | pigment granule transport(GO:0051904) |
0.0 | 0.0 | GO:0033483 | gas homeostasis(GO:0033483) |
0.0 | 0.1 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.3 | 1.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 0.6 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.2 | 0.2 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.2 | 1.6 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 1.0 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.2 | 0.5 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.2 | 0.9 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 0.5 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.7 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.5 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.7 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 0.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.5 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 0.4 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.4 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 1.3 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 0.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.2 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 1.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 1.2 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.1 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 1.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.3 | GO:0097513 | myosin II filament(GO:0097513) |
0.1 | 0.6 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.1 | 0.8 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 0.3 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 0.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.6 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 0.4 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 0.6 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.4 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.3 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.2 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.1 | 0.6 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 1.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.5 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 0.1 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.1 | 0.5 | GO:0070187 | telosome(GO:0070187) |
0.1 | 0.7 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 0.1 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 0.7 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 0.1 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.1 | 0.7 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.1 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.1 | 0.4 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.1 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 0.2 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 0.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 0.4 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.3 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 0.2 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.1 | 0.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.2 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.1 | 0.5 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 0.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.2 | GO:0035363 | histone locus body(GO:0035363) |
0.1 | 0.9 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.2 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.2 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.2 | GO:0033269 | internode region of axon(GO:0033269) |
0.0 | 0.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.1 | GO:0097413 | Lewy body(GO:0097413) |
0.0 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.4 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.0 | 0.2 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 3.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.4 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.8 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.3 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.0 | 0.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.2 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.0 | 2.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.1 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.0 | 0.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.2 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.0 | 0.9 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.4 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.2 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.7 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.0 | 0.1 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.0 | 0.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.4 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 0.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 1.0 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.4 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.3 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.1 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 0.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 0.3 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 0.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.1 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.0 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.2 | GO:0043203 | axon hillock(GO:0043203) |
0.0 | 0.5 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 0.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 1.0 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.3 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.2 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.0 | 0.0 | GO:0032437 | cuticular plate(GO:0032437) |
0.0 | 0.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 0.4 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 2.1 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 0.2 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.4 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.0 | 0.1 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.0 | 0.2 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.1 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.0 | 0.1 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.0 | 9.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.0 | 0.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.3 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.1 | GO:0097452 | GAIT complex(GO:0097452) |
0.0 | 0.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.3 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 0.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.3 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.2 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 1.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.0 | 1.4 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.0 | 0.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.2 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.0 | 0.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.5 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.0 | 0.1 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.0 | 1.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.6 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.0 | 0.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.1 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.1 | GO:0031983 | vesicle lumen(GO:0031983) |
0.0 | 0.5 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.0 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 0.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.1 | GO:0042825 | TAP complex(GO:0042825) |
0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 1.3 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.3 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.0 | 0.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.0 | 2.0 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.2 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.1 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.2 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.0 | 0.4 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.4 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.0 | 0.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.3 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 1.4 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.2 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 0.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.3 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 0.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 0.1 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.0 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.0 | 0.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.0 | 0.5 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.0 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 0.1 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.0 | 0.1 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.0 | 0.0 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.0 | 0.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.0 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 0.1 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.0 | 0.3 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 0.0 | GO:0000243 | commitment complex(GO:0000243) |
0.0 | 0.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.0 | 0.3 | GO:0044452 | nucleolar part(GO:0044452) |
0.0 | 0.4 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.3 | GO:0008305 | integrin complex(GO:0008305) |
0.0 | 0.0 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.0 | 0.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.5 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.0 | GO:0098536 | deuterosome(GO:0098536) |
0.0 | 0.0 | GO:0097422 | tubular endosome(GO:0097422) |
0.0 | 0.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.0 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 0.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.0 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.0 | 0.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.0 | 0.3 | GO:0031082 | BLOC complex(GO:0031082) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.1 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.0 | 0.0 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.0 | 0.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.0 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.0 | 0.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 1.0 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 0.1 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.0 | GO:1990423 | RZZ complex(GO:1990423) |
0.0 | 0.3 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.0 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.0 | 0.1 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.0 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.0 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.0 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.0 | 0.0 | GO:0061702 | inflammasome complex(GO:0061702) |
0.0 | 0.0 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.0 | 0.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 1.1 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.4 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.1 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.9 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.3 | 0.8 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 0.7 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.2 | 1.6 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 1.1 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.2 | 0.6 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 0.4 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 1.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 0.9 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 0.5 | GO:0032551 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.2 | 0.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 0.5 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.2 | 0.6 | GO:0015265 | urea channel activity(GO:0015265) |
0.1 | 0.4 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 1.2 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.1 | 0.4 | GO:1990188 | euchromatin binding(GO:1990188) |
0.1 | 0.4 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.1 | 0.3 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 0.5 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.1 | 1.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.8 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.8 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.4 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.4 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.1 | 0.6 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.1 | 0.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.3 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 0.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.2 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 0.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.2 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.1 | 0.9 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.4 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.4 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.4 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.8 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 0.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.3 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.1 | 0.5 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.9 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 1.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.8 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 1.4 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 0.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.1 | 0.4 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.5 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.1 | 0.5 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.8 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 1.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 0.1 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription corepressor binding(GO:0001226) |
0.1 | 0.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 0.3 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.3 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 0.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.2 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 0.2 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 0.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.9 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.7 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 2.3 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.4 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.7 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.2 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.1 | 0.2 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.2 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.1 | 1.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 1.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.9 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.2 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.1 | 0.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.9 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.3 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.3 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.3 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.5 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.6 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 0.3 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 0.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.1 | 0.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.1 | 0.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.4 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.4 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.3 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 0.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.2 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.1 | 0.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.2 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 0.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 0.2 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.1 | 0.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.2 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.2 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.1 | 0.2 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 0.2 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.1 | 0.5 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.1 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.2 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 0.6 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.2 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.1 | 0.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.4 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.5 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.5 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 0.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.3 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 0.3 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.1 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.1 | 0.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.5 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.0 | 0.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.1 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.0 | 0.3 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.0 | 0.2 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.0 | 0.6 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.0 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.0 | 0.1 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.0 | 0.2 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.0 | 0.8 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.0 | 0.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.0 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 12.8 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.0 | 0.1 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.0 | 0.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.1 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.0 | 0.2 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.9 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.0 | 0.2 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 0.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.3 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.0 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.0 | 0.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.1 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.0 | 0.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 1.6 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.2 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.0 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.3 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.0 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.0 | 0.8 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 1.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.0 | 0.1 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.0 | 0.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.1 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.1 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.0 | 0.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.1 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.0 | 0.0 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.0 | 0.2 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.1 | GO:0051425 | PTB domain binding(GO:0051425) |
0.0 | 0.1 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 0.4 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.2 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.2 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 17.7 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.0 | 0.1 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.0 | 0.3 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.3 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.2 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.0 | 0.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 0.1 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.0 | 0.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.3 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 3.2 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.2 | GO:0070635 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.0 | 0.1 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.0 | 0.2 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.1 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.1 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.0 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 1.0 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.0 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.0 | 0.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.0 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.0 | 0.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.0 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.0 | 0.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.1 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.0 | 1.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.0 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.2 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.2 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.1 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.1 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.1 | GO:0034838 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.0 | 0.2 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.2 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.0 | 0.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 4.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.0 | 0.2 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.3 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 0.0 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.0 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.0 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.5 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.2 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 0.3 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
0.0 | 0.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.1 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.0 | 0.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.0 | 0.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.0 | 0.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.1 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.0 | 0.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.0 | 0.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.0 | 0.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.0 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.0 | 0.2 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.0 | 0.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.0 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.1 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.0 | 0.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 1.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.0 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.0 | 0.2 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 0.2 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.0 | 0.1 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.3 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.2 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 0.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 1.6 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.0 | 0.0 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.4 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.2 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 0.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.2 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.1 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.0 | 0.1 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.0 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.0 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.0 | 0.1 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.2 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.0 | 0.1 | GO:0018447 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.0 | 0.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.1 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.0 | 0.0 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.3 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.0 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.0 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.0 | 0.0 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.2 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 0.1 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 0.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.1 | GO:0017099 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.0 | 0.0 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.0 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.0 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.0 | 0.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 1.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.4 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.0 | GO:0004359 | glutaminase activity(GO:0004359) |
0.0 | 0.0 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.0 | 0.2 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 0.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 1.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.0 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.0 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.0 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.0 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.2 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.0 | 0.0 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.0 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.0 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.6 | GO:0000975 | regulatory region DNA binding(GO:0000975) |
0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.0 | 0.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.0 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 1.5 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.0 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.3 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.0 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 0.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.0 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.0 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.0 | 1.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.0 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.0 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.0 | 0.0 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 0.0 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 0.4 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.0 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.0 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.0 | 0.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.0 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.0 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.0 | 0.0 | GO:0050997 | quaternary ammonium group binding(GO:0050997) |
0.0 | 0.3 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.2 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 0.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.1 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.0 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 2.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 3.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.8 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 3.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 3.1 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 1.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 0.7 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.5 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 0.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 0.7 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 1.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.4 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.5 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 1.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 1.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 1.2 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 1.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 1.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.8 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.5 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.5 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 1.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.4 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 1.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 6.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 3.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 5.4 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.6 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.4 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.2 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.4 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.1 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.2 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.1 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.2 | 0.8 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.2 | 0.3 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 1.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 1.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 0.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 1.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 0.5 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 1.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 2.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 0.2 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.1 | 0.9 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 0.1 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.1 | 1.9 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 3.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 1.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 2.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.1 | 1.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 0.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 0.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 1.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 1.0 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 1.0 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 1.3 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 0.6 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 0.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 0.1 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 0.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.8 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 4.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 0.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 0.3 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 0.6 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 3.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.1 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.5 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.2 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 0.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.4 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.9 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.1 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.0 | 0.4 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.3 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.0 | 0.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 1.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.1 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.6 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 2.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.0 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.0 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.2 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.0 | 0.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.1 | REACTOME ADAPTIVE IMMUNE SYSTEM | Genes involved in Adaptive Immune System |
0.0 | 0.1 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 0.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.4 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.3 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.1 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.3 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.0 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.0 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.1 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.4 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 0.1 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.0 | 0.0 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 0.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.1 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.0 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.1 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.0 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 0.5 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.0 | 0.1 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.0 | 0.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.0 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.1 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.1 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |